CRA (NASDAQ:CRAI) Reports Bullish Q2 CY2026

CRA International (NASDAQ:CRAI) reported Q2 CY2026 revenue of $210.8 million, up 12.8% year over year, exceeding Wall Street’s revenue estimate by 6%, according to the company and analysts. Non-GAAP adjusted EPS was $2.16, up from $1.88 a year earlier and 0.6% above consensus. The stock rose 1.9% to $179.96 after results.

Original reporting
Published Aug 6, 2026, 1:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 1:59 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
CRA (NASDAQ:CRAI) Reports Bullish Q2 CY2026 — source image
Decision brief

The 30-second read

$CRAIBullishMed
01

Why it matters

Q2 results beat revenue expectations and adjusted EPS was slightly above consensus, but the article flags expected revenue growth deceleration over the next year and stable margins.

02

Market read

This is a company-specific earnings beat with a reported same-day stock reaction, plus a forward growth deceleration that can drive near-term positioning and volatility.

03

What to watch

Adjusted operating margin is described as stable rather than improving, so traders may question whether revenue growth is translating into durable operating leverage.

Relevance 7/10Novelty 6/10Timing: post-results, same-day reaction reported

Background

CRA International is an economic and management consulting firm serving litigation, regulatory, and business strategy needs.

Company-level read

Ticker impact

$CRAIBullishMedium confidence
Context

CRA International reported Q2 CY2026 revenue up 12.8% to $210.8M and adjusted EPS of $2.16, beating revenue expectations.

Expected impact

Likely supports continued post-earnings bid, though upside may fade if traders focus on the expected revenue growth deceleration to 1.6% over the next 12 months.

Evidence & confidence

The article provides concrete Q2 results versus consensus and notes a same-day stock pop of 1.9%, but it also highlights weaker forward revenue growth expectations.

Market effects

Adds a data point that business-services demand and margins can hold up, but the forward deceleration narrative may limit sector-wide enthusiasm.

No specific regional spillover described.

No global macro or cross-border catalyst described.

Counterpoint

The forward revenue growth expectation (1.6% over 12 months) suggests the beat may not translate into sustained acceleration, limiting multiple expansion.

Key entities

  • CRA International

    Subject of the article, reporting Q2 CY2026 results and discussing revenue, EPS, and margin trends.

  • Wall Street analysts

    Referenced for consensus revenue and EPS expectations and forward growth estimates.

Related articles

$CRAIMedAI 8/10

CRA International, Inc. Q2 2026 Earnings Call Summary

CRA International reported Q2 2026 record quarterly revenue, up 12.8% year over year, with 95% of its portfolio contributing. Full-year 2026 revenue guidance was raised to $805 million to $820 million, with non-GAAP EBITDA margin of 12.0% to 13.0%. The company expanded its $400 million credit facility and returned $31.4 million to shareholders.

$CRAIMed

CRA INTERNATIONAL, INC. (CRAI): Results of Operations and Financial Condition

CRA INTERNATIONAL, INC. (CRAI) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.2 3 craiq2-20268xkexx992xcfore.htm EX-99.2 Document Exhibit 99.2 CHARLES RIVER ASSOCIATES (CRA) SECOND QUARTER FISCAL YEAR 2026 EARNINGS ANNOUNCEMENT PREPARED CFO REMARKS CRA is providing these prepared remarks by CFO Eric Nierenberg in combination with its press release. T

$DTMedAI 8/10

Dynatrace Springs on Q1 Figures

Dynatrace (NYSE: DT) reported Q1 FY2027 results for the quarter ended June 30, 2026. Total ARR was $2,136 million, up 17%. Total revenue rose to $555 million, up 16%. Subscription revenue was $530 million. GAAP operating income was $71 million and non-GAAP $162 million. CEO Rick McConnell cited 41% organic net new ARR growth and accelerating TTM growth.

$DBXMed

Dropbox Shares Decline Despite Earnings Beat as Revenue Growth Disappoints

Dropbox (DBX) shares fell about 5% premarket to around $32.80 after Q2 2026 results. The company reported adjusted EPS of $0.75 vs $0.74 expected and revenue of $631.5M vs about $627M, but revenue rose only 0.9% year over year. Non-GAAP operating margin improved to 39.7%. Paying users reached 18.19M. William Blair upgraded to Market Perform, while consensus remains Sell.

$HLMedAI 8/10

Hecla Mining Q2 Earnings Call Highlights

Hecla Mining reported Q2 financial and operating updates. The company ended the quarter with $483 million cash, about $472 million net cash, and an essentially undrawn $225 million revolver. It projected 2026 free cash flow of about $500 million at $50 silver and $3,500 gold, and raised Greens Creek silver guidance to 8.0-8.3 million ounces. Production guidance was adjusted for Lucky Friday and Keno Hill.

$RCELHighAI 9/10

Avita Medical Shares Surge After Record Second-Quarter Performance

Avita Medical (NASDAQ:RCEL) shares rose about 21.7% in premarket after it reported record Q2 results. Revenue was $21.7M, up 18% YoY and about 8% above estimates. Adjusted loss per share narrowed to $0.25 vs $0.30 expected. Full-year 2026 revenue guidance raised to $86M-$89M and cash-flow breakeven targeted for Q4 2026. BTIG upgraded to Buy with a $7.00 target.